Markt oder Branche auswählen:
Chart-Typ:
Zeitraum:
| Panasonic baut neues Werk in Thailand für Materialien zur KI-Server-Produktion | Panasonic Industry will seine Kapazitäten für Spezialmaterialien im Bereich Leiterplatten deutlich ausbauen. Das Unternehmen investiert rund 17 Milliarden Yen (etwa 105 Millionen Euro) in ein neues... ► Artikel lesen |
| Panasonic Industry To Invest JPY 17 Bln To Meet Rising AI Server Demand | TOKYO (dpa-AFX) - Panasonic Corporation's (PCRFF.PK, PCRFY.PK, 6752.T) Panasonic Industry Co., Ltd. said on Friday that it will invest around JPY 17 billion to construct a new production facility... ► Artikel lesen |
| Panasonic testing new energy management system to combine solar, heat pumps, batteries | The Japanese company said the first pilot projects are being carried out in the Tokyo metropolitan area with the support of Japanese oil giant Eneos. Japanese electronics manufacturer Panasonic announced... ► Artikel lesen |
| Research and Markets: Europe Liver Disease Therapeutic Market Analysis Report 2025-2033 Featuring Abbott, Astellas, BMS, Gilead Sciences, GSK, F. Hoffman-La Roche, Merck & Co., Novartis, Sanofi, Pfizer, Takeda - ResearchAndMarkets.com | The "Europe Liver Disease Therapeutic Market Forecast 2025" report has been added to ResearchAndMarkets.com's offering.
The Europe Liver Disease Therapeutic Market is expected to grow from US$... ► Artikel lesen |
| FDA Approves Expanded Indication For Takeda's VONVENDI In Von Willebrand Disease | TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TAK, TKPHF, 4502.T) announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application... ► Artikel lesen |
| Takeda's Fruzaqla Publicly Reimbursed In Quebec For Treatment Of Metastatic Colorectal Cancer | TOKYO (dpa-AFX) - Takeda Canada Inc. Thursday announced that Fruzaqlatm (fruquintinib capsules) will now be reimbursed by Régie de l'assurance maladie for people in Quebec, under certain criteria... ► Artikel lesen |
| Cosmo Pharma Renews Global Manufacturing Deal With Takeda For Ulcerative Colitis Drug | DUBLIN (dpa-AFX) - Cosmo Pharmaceuticals N.V. (COPN.SW) announced the renewal of its multi-year manufacturing and supply agreement with Takeda.As per the deal, Cosmo will continue producing... ► Artikel lesen |
| Cosmo Pharmaceuticals N.V.: Cosmo and Takeda Renew Strategic Manufacturing Agreement for Global Supply of Oral Treatment for Ulcerative Colitis | Dublin, Ireland--(Newsfile Corp. - August 8, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-driven healthcare and specialty pharmaceuticals, today announced the renewal of... ► Artikel lesen |
| Takeda Pharmaceutical Company Limited Q1 Profit Rises | TOKYO (dpa-AFX) - Takeda Pharmaceutical Company Limited (TKPHF.PK) released earnings for its first quarter that Increases, from the same period last yearThe company's bottom line came in at... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .